Frontotemporal dementia mutant tau (P301L) locks Fyn in an open, active conformation conducive to nanoclustering
暂无分享,去创建一个
[1] J. Götz,et al. Fyn Kinase Controls Tau Aggregation In Vivo. , 2020, Cell reports.
[2] T. Golde,et al. Fyn depletion ameliorates tauP301L-induced neuropathology , 2020, Acta Neuropathologica Communications.
[3] S. Strittmatter,et al. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy , 2020, Acta Neuropathologica Communications.
[4] P. Verstreken,et al. Need for speed: Super-resolving the dynamic nanoclustering of syntaxin-1 at exocytic fusion sites , 2020, Neuropharmacology.
[5] J. Sibarita,et al. Real-time nanoscale organization of amyloid precursor protein. , 2020, Nanoscale.
[6] Jonathan R Roth,et al. A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity , 2019, Neurobiology of Disease.
[7] Dongxue Wang,et al. Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay. , 2019, Journal of molecular graphics & modelling.
[8] Ramón Martínez-Mármol,et al. Frontotemporal dementia mutant Tau promotes aberrant Fyn nanoclustering in hippocampal dendritic spines , 2019, eLife.
[9] Nicolas L. Fawzi,et al. The SH3 domain of Fyn kinase interacts with and induces liquid–liquid phase separation of the low-complexity domain of hnRNPA2 , 2018, The Journal of Biological Chemistry.
[10] J. Attems,et al. Phosphorylation of different tau sites during progression of Alzheimer’s disease , 2018, Acta Neuropathologica Communications.
[11] Martin Hruska,et al. Synaptic nanomodules underlie the organization and plasticity of spine synapses , 2018, Nature Neuroscience.
[12] E. Mandelkow,et al. Multivalent cross-linking of actin filaments and microtubules through the microtubule-associated protein Tau , 2017, Nature Communications.
[13] G. Goodhill,et al. Visualizing endocytic recycling and trafficking in live neurons by subdiffractional tracking of internalized molecules , 2017, Nature Protocols.
[14] J. Götz,et al. Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation , 2017, The EMBO journal.
[15] Antoine Triller,et al. Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions , 2017, Neuron.
[16] L. Mao,et al. An Essential Role of Fyn in the Modulation of Metabotropic Glutamate Receptor 1 in Neurons , 2017, eNeuro.
[17] K. Vossel,et al. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture , 2017, Molecular Neurodegeneration.
[18] Rosemary J. Jackson,et al. Tau association with synaptic vesicles causes presynaptic dysfunction , 2017, Nature Communications.
[19] O. Hantschel,et al. Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies , 2017, Journal of molecular biology.
[20] Geoffrey J. Goodhill,et al. In vivo single-molecule imaging of syntaxin1A reveals polyphosphoinositide- and activity-dependent trapping in presynaptic nanoclusters , 2016, Nature Communications.
[21] T. Lenaerts,et al. Dynamically Coupled Residues within the SH2 Domain of FYN Are Key to Unlocking Its Activity. , 2016, Structure.
[22] E. Hosy,et al. The Munc18-1 domain 3a hinge-loop controls syntaxin-1A nanodomain assembly and engagement with the SNARE complex during secretory vesicle priming , 2016, The Journal of cell biology.
[23] Y. Gambin,et al. Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation , 2016, The Journal of cell biology.
[24] W. Noble,et al. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease , 2016, Acta neuropathologica communications.
[25] S. Raghavachari,et al. Protein Crowding within the Postsynaptic Density Can Impede the Escape of Membrane Proteins , 2016, The Journal of Neuroscience.
[26] G. Besra,et al. The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells , 2016, Proceedings of the National Academy of Sciences.
[27] B. Kay,et al. Directed Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase , 2016, PloS one.
[28] Brendan Santyr,et al. Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5 , 2015, Nature Communications.
[29] S. Strittmatter,et al. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice , 2015, Annals of neurology.
[30] L. Blanchoin,et al. Tau co-organizes dynamic microtubule and actin networks , 2015, Scientific Reports.
[31] D. Xia,et al. Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines. , 2015, Biochimica et biophysica acta.
[32] Daniel Choquet,et al. Glutamate-Induced AMPA Receptor Desensitization Increases Their Mobility and Modulates Short-Term Plasticity through Unbinding from Stargazin , 2015, Neuron.
[33] R. Bostwick,et al. AlphaScreen HTS and Live-Cell Bioluminescence Resonance Energy Transfer (BRET) Assays for Identification of Tau–Fyn SH3 Interaction Inhibitors for Alzheimer Disease , 2014, Journal of biomolecular screening.
[34] T. Smithgall,et al. Differential Sensitivity of Src-Family Kinases to Activation by SH3 Domain Displacement , 2014, PloS one.
[35] D. Xia,et al. Premature lethality, hyperactivity, and aberrant phosphorylation in transgenic mice expressing a constitutively active form of Fyn , 2014, Front. Mol. Neurosci..
[36] A. Buisson,et al. Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers , 2014, The Journal of Neuroscience.
[37] R. Huganir,et al. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced AMPA glutamate receptor signaling deficits , 2014, The European journal of neuroscience.
[38] M. Goedert,et al. Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice , 2013, Acta neuropathologica communications.
[39] Daniel Choquet,et al. Super-Resolution Imaging Reveals That AMPA Receptors Inside Synapses Are Dynamically Organized in Nanodomains Regulated by PSD95 , 2013, The Journal of Neuroscience.
[40] T. Mulhern,et al. Tyrosine 416 Is Phosphorylated in the Closed, Repressed Conformation of c-Src , 2013, PloS one.
[41] J. DeFelipe,et al. The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease , 2013, Brain : a journal of neurology.
[42] Mark S. P. Sansom,et al. Reduced Lateral Mobility of Lipids and Proteins in Crowded Membranes , 2013, PLoS Comput. Biol..
[43] Nancy T. Malintan,et al. Myosin VI small insert isoform maintains exocytosis by tethering secretory granules to the cortical actin , 2013, The Journal of cell biology.
[44] D. Bennett,et al. The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease , 2012, The Journal of Neuroscience.
[45] A. Vortmeyer,et al. Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.
[46] B. Kay,et al. Isolation of monobodies that bind specifically to the SH3 domain of the Fyn tyrosine protein kinase. , 2012, New biotechnology.
[47] W. Noble,et al. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau , 2011, The FEBS journal.
[48] Yoshihisa Kubota,et al. The impacts of geometry and binding on CaMKII diffusion and retention in dendritic spines , 2011, Journal of Computational Neuroscience.
[49] Jürgen Götz,et al. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.
[50] K. Ashe,et al. Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.
[51] S. Yen,et al. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy , 2010, Neuropathology and applied neurobiology.
[52] E. Mandelkow,et al. Fyn-Tau-Amyloid: A Toxic Triad , 2010, Cell.
[53] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[54] Omer Dushek,et al. Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal Transduction , 2010, Immunity.
[55] W. Klein,et al. Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.
[56] Kousuke Kasahara,et al. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain , 2009, Journal of Cell Science.
[57] M. Zvelebil,et al. Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases* , 2008, Journal of Biological Chemistry.
[58] I. Bahar,et al. Structure and dynamic regulation of Src-family kinases , 2008, Cellular and Molecular Life Sciences.
[59] W. Miller,et al. Cooperative activation of Src family kinases by SH3 and SH2 ligands. , 2007, Cancer letters.
[60] S. Yen,et al. Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.
[61] L. Mucke,et al. Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[62] D. Lawrence,et al. Acquisition of Fyn-selective SH3 domain ligands via a combinatorial library strategy. , 2005, Chemistry & biology.
[63] L. Mucke,et al. Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice , 2004, The Journal of Neuroscience.
[64] G. V. Van Hoesen,et al. Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.
[65] P. Cohen,et al. The specificities of protein kinase inhibitors: an update. , 2003, The Biochemical journal.
[66] M. Vitek,et al. Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[68] Giulio Superti-Furga,et al. Dynamic Coupling between the SH2 and SH3 Domains of c-Src and Hck Underlies Their Inactivation by C-Terminal Tyrosine Phosphorylation , 2001, Cell.
[69] Shoji Komai,et al. Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.
[70] L. Toledo,et al. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. , 2000, Structure.
[71] T. Smithgall,et al. SH2-Kinase Linker Mutations Release Hck Tyrosine Kinase and Transforming Activities in Rat-2 Fibroblasts* , 1999, The Journal of Biological Chemistry.
[72] S. Nakanishi,et al. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[73] H. Band,et al. Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.
[74] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[75] D. Bredt,et al. N-Terminal Palmitoylation of PSD-95 Regulates Association with Cell Membranes and Interaction with K+ Channel Kv1.4 , 1998, Neuron.
[76] J. Kuriyan,et al. Structures of Src-family tyrosine kinases. , 1997, Current opinion in structural biology.
[77] I D Campbell,et al. Solution structure and peptide binding of the SH3 domain from human Fyn. , 1996, Structure.
[78] J. Hanke,et al. Role of tyrosine kinases in lymphocyte activation: Targets for drug intervention , 1995, Inflammation Research.
[79] R. Pepperkok,et al. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[80] E. Kandel,et al. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.
[81] Jürgen Götz,et al. Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies , 2018, Nature Reviews Neurology.
[82] J. DeFelipe,et al. Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[83] M. Vitek,et al. Tau is essential to beta -amyloid-induced neurotoxicity. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[84] S. Komai,et al. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. , 2001, The Journal of biological chemistry.
[85] S. Courtneidge,et al. Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation. , 1992, Oncogene.